| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.46B | 40.55B | 55.38B | 39.73B | 29.55B | 30.29B |
| Gross Profit | 4.25B | 4.25B | 4.23B | 3.99B | 4.88B | 3.72B |
| EBITDA | 3.53B | 3.36B | 1.77B | 1.23B | 2.38B | 1.41B |
| Net Income | 1.25B | 1.27B | 625.00M | 328.00M | 1.34B | 776.00M |
Balance Sheet | ||||||
| Total Assets | 64.50B | 69.32B | 76.83B | 61.13B | 52.53B | 49.94B |
| Cash, Cash Equivalents and Short-Term Investments | 9.12B | 10.32B | 6.59B | 7.88B | 12.34B | 8.93B |
| Total Debt | 14.99B | 19.35B | 21.28B | 12.22B | 9.00B | 9.97B |
| Total Liabilities | 32.61B | 37.49B | 43.76B | 31.27B | 22.98B | 21.91B |
| Stockholders Equity | 31.88B | 31.83B | 32.53B | 29.38B | 29.12B | 27.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.73B | -9.72B | -7.60B | 4.61B | 2.70B |
| Operating Cash Flow | 0.00 | 8.18B | -8.58B | -6.50B | 4.82B | 3.49B |
| Investing Cash Flow | 0.00 | -869.00M | -146.00M | -643.00M | 37.00M | -2.52B |
| Financing Cash Flow | 0.00 | -3.59B | 7.43B | 2.68B | -1.45B | -686.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥9.67B | -81.16 | ― | 3.74% | -29.79% | 278.17% | |
71 Outperform | ¥8.85B | -10.52 | ― | 4.38% | -16.09% | -163.96% | |
70 Outperform | ¥7.01B | 16.94 | ― | 3.77% | 11.25% | 26.01% | |
70 Outperform | ¥7.89B | 16.79 | ― | 2.03% | 16.10% | -10.63% | |
70 Outperform | ¥15.61B | 6.90 | ― | 1.39% | 2.98% | 11.88% | |
69 Neutral | ¥8.58B | 17.68 | ― | 4.94% | -4.23% | -64.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |